SCHEMBL2184267

SCHEMBL2184267

CC(C)=CCC1(C)CC(C)C=C(C)C1=O

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 3/20 0.36
IKBKB O14920 1/20 0.33
PNLIP P16233 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2183039 0.72 CYP3A4 (0.31)
SCHEMBL14458059 0.69 ABCB1 (0.30)
SCHEMBL2184334 0.68
SCHEMBL4423005 0.65 IKBKB (0.36) IKBKBPNLIP
SCHEMBL11278684 0.64 PTPN1 (0.36) IKBKBPNLIP
SCHEMBL27084024 0.64 PTPN1 (0.36) IKBKBPNLIP
SCHEMBL4412683 0.64
SCHEMBL18603988 0.64 PTPN1 (0.36) IKBKBPNLIP
SCHEMBL2183023 0.62 IKBKB (0.32) IKBKB
SCHEMBL4415300 0.61 XDH (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4356894-A1 SUSTAINABLE PRODUCT WITH MALODORS Beiersdorf AG (DE) 2024-04-24 EP claimed
WO-2011084492-A1 TRASH BAG WITH MALODOR CONTROL THE GLAD PRODUCTS COMPANY (US) 2011-07-14 WO claimed
US-20110164834-A1 TRASH BAG WITH MALODOR CONTROL THE GLAD PRODUCTS COMPANY (US) 2011-07-07 US claimed
EP-4356894-A1 SUSTAINABLE PRODUCT WITH MALODORS Beiersdorf AG (DE) 2024-04-24 EP disclosed
WO-2011084492-A1 TRASH BAG WITH MALODOR CONTROL THE GLAD PRODUCTS COMPANY (US) 2011-07-14 WO disclosed
US-20110164834-A1 TRASH BAG WITH MALODOR CONTROL THE GLAD PRODUCTS COMPANY (US) 2011-07-07 US disclosed
EP-1339659-B1 SUBSTITUTED CYCLOHEXENES GIVAUDAN SA (CH) 2009-02-04 EP disclosed
US-7078570-B2 Substituted cyclohexenes GIVAUDAN SA (CH) 2006-07-18 US disclosed
US-20040073050-A1 Substituted cyclohexenes GIVAUDAN SA (CH) 2004-04-15 US disclosed
EP-1339659-A1 SUBSTITUTED CYCLOHEXENES Givaudan SA (CH) 2003-09-03 EP disclosed
WO-2002046131-A1 SUBSTITUTED CYCLOHEXENES GIVAUDAN SA (CH) 2002-06-13 WO disclosed
EP-1213276-A1 Substituted cyclohexenes Givaudan SA (CH) 2002-06-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040073050-A1 Substituted cyclohexenes CDY1; CDY1B, CDYL, MYB NFE2L2 747/4885IKBKB 2054/4885PNLIP 2792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.